Workplace Sexual Harassment Linked to Higher Risk of Cardiometabolic Diseases: Daily Dose
Your daily dose of the clinical news you may have missed.
Prenatal RSV Vaccine Not Associated with Preterm Birth, According to First Real-World Data
Data from a study performed during the first season the shot was available expand on clinical trial evidence and support the safety of RSVpreF, authors wrote.
Weight Loss with Tirzepatide Significantly Greater than with Semaglutide: New Data
Tirzepatide-treated participants were 3 times more likely than those treated with semaglutide to reach weight loss of 15% or greater, the head-to-head study found.
GLP-1RAs Linked to Decreased Risk of Some Obesity-Related Cancers in Patients with T2D
GLP-1RAs were associated with a significantly reduced risk of obesity-associated cancers including gallbladder cancer, pancreatic cancer, and meningioma.
FDA Approves Ensifentrine for Maintenance Treatment of COPD in Adults: Daily Dose
More Than 60% of US Adults Unaware Primary Care Clinicians Can Prescribe Medications for Opioid Use Disorder
Findings from a national survey also showed that Black respondents were most likely to believe they could not receive medications for OUD at a PCP.
Aspirin Still Used for Primary Prevention among Older Americans Without CVD: Daily Dose
Exercise Plus GLP-1 RA May Preserve BMD During Weight Loss, Study Finds
The preserved bone mass observed in participants taking liraglutide and exercising was seen despite weight reduction levels similar to outcomes with semaglutide and tirzepatide.
Lilly's Donanemab Approved by FDA for Treatment of Early Symptomatic AD
Donanemab, now 1 of 2 antiamyloid medications available, is unique based on evidence that it can be used in limited duration treatment, based on removal of plaque.
First Consensus Guidance Published on Monitoring Early-Stage Type 1 Diabetes
The international statement targets primary care clinicians and endocrinologists with detailed guidance on monitoring disease progression and providing education.
UPDATE: ACIP Vote Unanimous to Recommend Merck 21-Valent Pneumococcal Shot for Older Adults
The novel vaccination is recommended as an option for adults aged 65 years and older who have not received a pneumococcal conjugate vaccine.
Workplace Sexual Harassment Tied to Higher Risk of CVD, T2D in Men and Women
The risk for developing CVD and T2D was highest among individuals who frequently experienced the behavior in the workplace, according to new study.
Sex Disparities in Long-Term Lipid Management: Daily Dose
Walmart Closing All Health Centers, Ending Virtual Care Offerings
After a 5-year trial, the company is ending its entry into health care, citing the lack of a "sustainable business model."
Emerging Therapies in Management of Congenital Adrenal Hyperplasia
Investigational treatments for congenital adrenal hyperplasia are focused on new ways to manage symptoms without the need for supraphysiologic doses of glucocorticoids.
CDC Updates COVID-19, Influenza Vaccine Recommendations for 2024-2025 Respiratory Virus Season
Individuals 6 months and older should receive updated COVID-19 and influenza vaccines for the 2024-2025 respiratory virus season, the agency recommended.
Prevalence of Chronic HTN During Pregnancy in US: Daily Dose
Seen in the ED: Popcorn Kernel
After performing a back blow maneuver on her 10-month-old daughter to dislodge a popcorn kernel, a mother arrives at the ED with the child in distress. What happened?
ACIP Revises Recommendation for Adult RSV Vaccination
The committee endorsed a universal recommendation for a single lifetime dose of RSV vaccine for adults aged ≥75 years and a risk-based recommendation for those aged 60 to 74 years.
SECURE-T2D: Automated Insulin Delivery System Reduced A1c in Adults with Type 2 Diabetes
ADA 2024. Adults started on the Omnipod 5 AID system had an A1c reduction from 8.2% at baseline to 7.4% at 13 weeks, researchers report.
